The National Pharmaceutical Council is pleased to share the 2016 Annual Report, detailing our research, activities and outreach from the past year. We addressed a wide array of crucial issues in health care, continuing to highlight research and discussions around our key issues of Evidence, Value, Access and Innovation.
NPC Testifies at FDA Meeting on Manufacturer Communications
NPC Vice President for Comparative Effectiveness Research Jennifer Graff, PharmD, testified before the Food and Drug Administration on "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products."
NPC Comments on Revised ICER Value Assessment Framework
NPC commented on the Institute of Clinical and Economic Review’s (ICER) updated value assessment framework, which was released on February 1, 2017. NPC plans to submit written comments to ICER on the revised framework.